Determinant Factors of the Quality of Life in Children with Osteogenesis Imperfecta during the COVID-19 Pandemic

Nur Rochmah; Rahma Ira Mustikasari; Muhammad Faizi; Irwanto Irwanto

doi:10.3889/oamjms.2022.9571

Authors

Nur Rochmah Department of Child Health, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia https://orcid.org/0000-0002-9626-9615
Rahma Ira Mustikasari Department of Child Health, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia
Muhammad Faizi Department of Child Health, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia
Irwanto Irwanto Department of Child Health, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia https://orcid.org/0000-0002-7573-8793

DOI:

https://doi.org/10.3889/oamjms.2022.9571

Keywords:

Osteogenesis imperfect, PedsQL, Determinant, COVID-19

Abstract

Background: Osteogenesis imperfecta (OI) is a common chronic illness with increasing prevalence. Coronavirus disease 2019 (COVID-19) and large society restriction policies in Indonesia cause problems and might affect the quality of life (QoL) of children with OI.

Objective: To evaluate determinant factors that affect OI children's QoL pre and during the first year of the COVID-19 pandemic.

Method: This was a cross-sectional study design conducted in the Pediatric Endocrinology Outpatient Clinic, Dr. Soetomo Hospital, Surabaya, Indonesia, during the COVID-19 pandemic in 2020 to assess the patient’s QoL. This study used a diagnostic group with questionnaires. The instrument included the Pediatric Quality of Life Inventory 4.0 Generic Score, a standardized interview questionnaire comprising questions on the participant characteristics and determinant factors pre and during the COVID-19 pandemic. Analysis of determinant factors pre and during the pandemic used McNemar. Correlation between determinant factors and QoL used linear regression for physical and emotional dimensions and logistic regression for social, school, and total score.

Result: Of the 22 children with OI, 19 had fear of visiting the hospital (p < 0.001), and 16 had obstacles to visiting the hospital (p < 0.01). The determinant factors for taking calcium and/or vitamin D supplementation pre and during the COVID-19 pandemic affected school functioning (p = 0.015) and the total score (p = 0.027).

Conclusion: The significant risk factors pre and during COVID-19 were fear of and obstacles to visiting the hospital. Supplementation of calcium and/or vitamin D pre and during the COVID-19 pandemic significantly impacted school functioning and the total score.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. https://doi.org/10.1542/peds.2020-0702 PMid:32179660 DOI: https://doi.org/10.1542/peds.2020-0702

Purnama SG, Susanna D. Attitude to COVID-19 Prevention with Large-Scale Social Restrictions (PSBB) in Indonesia: Partial least squares structural equation modeling. Front Public Health. 2020;8:570394. https://doi.org/10.3389/fpubh.2020.570394 PMid:33194970 DOI: https://doi.org/10.3389/fpubh.2020.570394

Brizola E, Adami G, Baroncelli GI, Bedeschi MF, Berardi P, Boero S, et al. Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic. Orphanet J Rare Dis. 2020;15(1):228. https://doi.org/10.1186/s13023-020-01513-6 PMid:32867855 DOI: https://doi.org/10.1186/s13023-020-01513-6

Nshimyiryo A, Barnhart DA, Cubaka VK, Dusengimana JM, Dusabeyezu S, Ndagijimana D, et al. Barriers and coping mechanisms to accessing healthcare during the COVID-19 lockdown: A cross-sectional survey among patients with chronic diseases in rural Rwanda. BMC Public Health. 2021;21(1):704. https://doi.org/10.1186/s12889-021-10783-z PMid:33838676 DOI: https://doi.org/10.1186/s12889-021-10783-z

Kretchy IA, Asiedu-Danso M, Kretchy J. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low- and middle-income countries. Res Social Adm Pharm. 2021;17(1):2023-6. https://doi.org/10.1016/j.sapharm.2020.04.007 PMid:32307319 DOI: https://doi.org/10.1016/j.sapharm.2020.04.007

Zhao C, Batio S, Lovett R, Pack AP, Wolf MS, Bailey SC. The relationship between covid-19 related stress and medication adherence among high-risk adults during the acceleration phase of the us outbreak. Patient Prefer Adherence. 2021;15:1895-902. https://doi.org/10.2147/PPA.S310613 PMid:34511885 DOI: https://doi.org/10.2147/PPA.S310613

Zhang G, Yang H, Zhang A, Shen Q, Wang L, Li Z, et al. The impact of the COVID-19 outbreak on the medical treatment of Chinese children with Chronic Kidney Disease (CKD): A multicenter cross-section study in the context of a public health emergency of international concern. MedRxiv 2020;32:1189-94 DOI: https://doi.org/10.1101/2020.02.28.20029199

Alshahrani M, Elyamany G, Sedick Q, Ibrahim W, Mohamed A, Othman M, et al. The impact of COVID-19 pandemic in children with cancer: A report from Saudi Arabia. Health Serv Insights. 2020;13:84161. https://doi.org/10.1177/1178632920984161 PMid:33447044 DOI: https://doi.org/10.1177/1178632920984161

Forlino A, Marini JC. Osteogenesis imperfecta. Lancet. 2016;387:1657-71. https://doi.org/10.1016/S0140-6736(15)00728-X PMid:26542481 DOI: https://doi.org/10.1016/S0140-6736(15)00728-X

Macovei S, Mandache RŞ. Osteogenesis imperfecta and its consequences on the disabled children’s capacity for effort and movement. Procedia Soc Behav Sci. 2014;117:67-73. DOI: https://doi.org/10.1016/j.sbspro.2014.02.180

Brizola E, Félix T, Shapiro J. Pathophysiology and therapeutic options in osteogenesis imperfecta: An update. Res Rep Endocr Disord. 2016;6:17-30. DOI: https://doi.org/10.2147/RRED.S96578

Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16(2):101-16. https://doi.org/10.1136/jmg.16.2.101 PMid:458828 DOI: https://doi.org/10.1136/jmg.16.2.101

Varni JW, Seid M, Kurtin PS. Peds QLTM 4 0: Reliability and validity of the pediatric quality of life inventory TM version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800-12. DOI: https://doi.org/10.1097/00005650-200108000-00006

Varni JW. SCALING AND SCORING OF THE Pediatric Quality of Life Inventory™ PedsQL™. Lyon: Mapi Research Trust; 1998. Available from: https://www.pedsql.org/score.html. [Last accessed on 2022 Mar 01].

Otaify GA, Aglan MS, Ibrahim MM, Elnashar M, El Banna RA, Temtamy SA. Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: A 2-year prospective observational study. Osteoporos Int. 2016;27:81-92. https://doi.org/10.1007/s00198-015-3216-9 DOI: https://doi.org/10.1007/s00198-015-3216-9

Palomo T, Vilaça T, Lazaretti-Castro M. Osteogenesis imperfecta: Diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes. 2017;24(6):381-8. https://doi.org/10.1097/MED.0000000000000367 PMid:28863000 DOI: https://doi.org/10.1097/MED.0000000000000367

Vuorimies I, Toiviainen-Salo S, Hero M, Mäkitie O. Zoledronic acid treatment in children with osteogenesis imperfecta. Horm Res Paediatr. 2011;75(5):346-53. https://doi.org/10.1159/000323368 PMid:21293106 DOI: https://doi.org/10.1159/000323368

Adıbelli D, Sümen A. The effect of the coronavirus (COVID-19) pandemic on health-related quality of life in children. Child Youth Serv Rev. 2020;119:105595. https://doi.org/10.1016/j.childyouth.2020.105595 PMid:33071408 DOI: https://doi.org/10.1016/j.childyouth.2020.105595

Sutthisompohn S, Kusol K. Association between caregivers’ family management and quality of life in children with chronic disease in Southern Thailand. Patient Prefer Adherence. 2021;15:2165-74. https://doi.org/10.2147/PPA.S327553 PMid:34588766 DOI: https://doi.org/10.2147/PPA.S327553

Newacheck PW, Strickland B, Shonkoff JP, Perrin JM, McPherson M, McManus M, et al. An epidemiologic profile of children with special health care needs. Pediatrics. 1998;102:117-23. https://doi.org/10.1542/peds.102.1.117 PMid:9651423 DOI: https://doi.org/10.1542/peds.102.1.117

Kabengo S, Munalula-Nkandu E, Munthali JC, Nkhata LA, Shula H. The prevalence and characteristics of patients diagnosed with osteogenesis imperfecta at the Zambia Italian Orthopedics Hospital community based Rehabilitation Project. Sci J Public Health. 2015;3(5):804-7. https://doi.org/10.11648/j.sjph.20150305.40 DOI: https://doi.org/10.11648/j.sjph.20150305.40

Rothschild L, Goeller JK, Voronov P, Barabanova A, Smith P. Anesthesia in children with osteogenesis imperfecta: retrospective chart review of 83 patients and 205 anesthetics over 7 years. Paediatr Anaesth. 2018;28(11):1050-8. https://doi.org/10.1111/pan.13504 PMid:30295359 DOI: https://doi.org/10.1111/pan.13504